Nicardipine vs. Labetalol

NCT07277283 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Acute Ischemic Stroke
Hypertensive Crisis

Interventions

DRUG: nicardipine intravenous
DRUG: labetalol intravenous

Sponsor

Haseki Training and Research Hospital